DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.02, $0.05 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $84.3 million versus the consensus estimate of $79.65 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.